Search Results - "Van den Bossche, Jolien" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study

by Van den Bossche, Jolien, De Laere, Maxime, Deschepper, Koen, Germonpré, Paul, Valcke, Yvan, Lamont, Jan, Stein, Barbara, Van Camp, Kirsten, Germonpré, Charlotte, Nijs, Griet, Roelant, Ella, Anguille, Sébastien, Lion, Eva, Berneman, Zwi
Published in PloS one (15.07.2024)

Get full text

Journal Article

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

by Deben, Christophe, Wouters, An, Op de Beeck, Ken, van Den Bossche, Jolien, Jacobs, Julie, Zwaenepoel, Karen, Peeters, Marc, Van Meerbeeck, Jan, Lardon, Filip, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Published in Oncotarget (08.09.2015)

Get full text

Journal Article

Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

by De Pauw, Ines, Lardon, Filip, Van den Bossche, Jolien, Baysal, Hasan, Fransen, Erik, Deschoolmeester, Vanessa, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Wouters, An
Published in Molecular oncology (01.06.2018)

Get full text

Journal Article

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

by Jacobs, Julie, Deschoolmeester, Vanessa, Zwaenepoel, Karen, Flieswasser, Tal, Deben, Christophe, Van den Bossche, Jolien, Hermans, Christophe, Rolfo, Christian, Peeters, Marc, De Wever, Olivier, Lardon, Filip, Siozopoulou, Vasiliki, Smits, Evelien, Pauwels, Patrick
Published in Oncoimmunology (03.07.2018)

Get full text

Journal Article

Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib

Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib

by De Pauw, Ines, Lardon, Filip, Van den Bossche, Jolien, Baysal, Hasan, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Wouters, An
Published in Cancers (15.01.2019)

Get full text

Journal Article

Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

by Van Genechten, Toon, De Laere, Maxime, Van den Bossche, Jolien, Stein, Barbara, De Rycke, kim, Deschepper, Caroline, Hazes, Katja, Peeters, Renke, Couttenye, Marie-Madeleine, Van De Walle, Katrien, Roelant, Ella, Maes, Sabine, Vanden Bossche, Stephanie, Dekeyzer, Sven, Huizing, Manon, Caluwaert, Kim, Nijs, Griet, Cools, Nathalie, Verlooy, Joris, Norga, Koen, Verhulst, Stijn, Anguille, Sebastien, Berneman, Zwi, Lion, Eva
Published in BMJ open (18.03.2024)

Get full text

Journal Article

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

by Bossche, Jolien, Deben, Christophe, De Pauw, Ines, Lambrechts, Hilde, Hermans, Christophe, Deschoolmeester, Vanessa, Jacobs, Julie, Specenier, Pol, Pauwels, Patrick, Vermorken, Jan Baptist, Peeters, Marc, Lardon, Filip, Wouters, An
Published in Molecular oncology (01.05.2019)

Get full text

Journal Article

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer

by Jacobs, Julie, Zwaenepoel, Karen, Rolfo, Christian, Van den Bossche, Jolien, Deben, Christophe, Silence, Karen, Hermans, Christophe, Smits, Evelien, Van Schil, Paul, Lardon, Filip, Deschoolmeester, Vanessa, Pauwels, Patrick
Published in Oncotarget (30.05.2015)

Get full text

Journal Article

Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status

Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status

by Van den Bossche, Jolien, Domen, Andreas, Peeters, Marc, Deben, Christophe, De Pauw, Ines, Jacobs, Julie, De Bruycker, Sven, Specenier, Pol, Pauwels, Patrick, Vermorken, Jan Baptist, Lardon, Filip, Wouters, An
Published in Cancers (28.11.2019)

Get full text

Journal Article

Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

by De Pauw, Ines, Wouters, An, Van den Bossche, Jolien, Deschoolmeester, Vanessa, Baysal, Hasan, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan B, Lardon, Filip
Published in Cancer biotherapy & radiopharmaceuticals (01.09.2017)

Get full text

Journal Article

Simultaneous targeting of EGFR , HER 2, and HER 4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

Simultaneous targeting of EGFR , HER 2, and HER 4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

by De Pauw, Ines, Lardon, Filip, Van den Bossche, Jolien, Baysal, Hasan, Fransen, Erik, Deschoolmeester, Vanessa, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Wouters, An
Published in Molecular oncology (01.06.2018)

Get full text

Journal Article

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

by Jacobs, Julie, Deschoolmeester, Vanessa, Rolfo, Christian, Zwaenepoel, Karen, Van den Bossche, Jolien, Deben, Christophe, Silence, Karen, de Haard, Hans, Hermans, Christophe, Rottey, Sylvie, Vangestel, Christel, Lardon, Filip, Smits, Evelien, Pauwels, Patrick
Published in Oncotarget (26.09.2017)

Get full text

Journal Article

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines

by Boeckx, Carolien, Van den Bossche, Jolien, De Pauw, Ines, Peeters, Marc, Lardon, Filip, Baay, Marc, Wouters, An
Published in BMC research notes (02.06.2015)

Get full text

Journal Article

APR-246 (PRIMA-1MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

APR-246 (PRIMA-1MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

by Deben, Christophe, Lardon, Filip, Wouters, An, Op de Beeck, Ken, van Den Bossche, Jolien, Jacobs, Julie, Van Der Steen, Nele, Peeters, Marc, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Published in Cancer letters (01.06.2016)

Get full text

Journal Article

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress

by Deben, Christophe, Deschoolmeester, Vanessa, De Waele, Jorrit, Jacobs, Julie, Van den Bossche, Jolien, Wouters, An, Peeters, Marc, Rolfo, Christian, Smits, Evelien, Lardon, Filip, Pauwels, Patrick
Published in Cancers (21.04.2018)

Get full text

Journal Article

Abstract 4102: Overcoming intrinsic and acquired cetuximab resistance: an in vitro study on the potential of afatinib in HNSCC cell lines

Abstract 4102: Overcoming intrinsic and acquired cetuximab resistance: an in vitro study on the potential of afatinib in HNSCC cell lines

by Pauw, Ines De, Wouters, An, Bossche, Jolien Van den, Deschoolmeester, Vanessa, Pauwels, Patrick, Vermorken, Jan B., Peeters, Marc, Lardon, Filip
Published in Cancer research (Chicago, Ill.) (01.07.2017)

Get full text

Journal Article

Abstract 1056: Volasertib in combination with radiotherapy: The perfect match in non-small cell lung cancer

Abstract 1056: Volasertib in combination with radiotherapy: The perfect match in non-small cell lung cancer

by Bossche, Jolien Van den, Pauw, Ines De, Lambrechts, Hilde, Merlin, Céline, Deben, Christophe, Deschoolmeester, Vanessa, Specenier, Pol, Pauwels, Patrick, Peeters, Marc, Lardon, Filip, Wouters, An
Published in Cancer research (Chicago, Ill.) (01.07.2017)

Get full text

Journal Article

Deep sequencing of the TP53 gene reveals a potential risk allele for non–small cell lung cancer and supports the negative prognostic value of TP53 variants

Deep sequencing of the TP53 gene reveals a potential risk allele for non–small cell lung cancer and supports the negative prognostic value of TP53 variants

by Deben, Christophe, Van den Bossche, Jolien, Van Der Steen, Nele, Lardon, Filip, Wouters, An, de Beeck, Ken Op, Hermans, Christophe, Jacobs, Julie, Peeters, Marc, Van Camp, Guy, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Published in Tumor biology (01.02.2017)

Get full text

Journal Article

Abstract 3507: APR-246 reactivates mutant p53 in non-small cell lung cancer cell lines and sensitizes cells for CDDP treatment under normoxic and hypoxic conditions

Abstract 3507: APR-246 reactivates mutant p53 in non-small cell lung cancer cell lines and sensitizes cells for CDDP treatment under normoxic and hypoxic conditions

by Deben, Christophe, Deschoolmeester, Vanessa, Wouters, An, Van den Bossche, Jolien, Jacobs, Julie, Lardon, Filip, Rolfo, Christian, Pauwels, Patrick
Published in Cancer research (Chicago, Ill.) (01.08.2015)

Get full text

Journal Article

Abstract 258: Is P53 the up-and-coming predictive biomarker for volasertib treatment in NSCLC

Abstract 258: Is P53 the up-and-coming predictive biomarker for volasertib treatment in NSCLC

by Van den Bossche, Jolien, Lardon, Filip, Deben, Christophe, De Pauw, Ines, Deschoolmeester, Vanessa, Smits, Evelien, Specenier, Pol, Pauwels, Patrick, Peeters, Marc, Wouters, An
Published in Cancer research (Chicago, Ill.) (15.07.2016)

Get full text

Journal Article